Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
about
Immunotherapy in renal cell carcinoma: latest evidence and clinical implications.The difference in the survival rate of patients with metastatic renal cell carcinoma in the intermediate-risk group of the Memorial Sloan Kettering Cancer Center criteria.Tumor matrix remodeling and novel immunotherapies: the promise of matrix-derived immune biomarkers.Targeting VEGFR2 with Ramucirumab strongly impacts effector/ activated regulatory T cells and CD8 T cells in the tumor microenvironmentSafety and efficacy of nivolumab in combination with sunitinib or pazopanib in advanced or metastatic renal cell carcinoma: the CheckMate 016 studyBiomarkers for predicting efficacy of PD-1/PD-L1 inhibitorsCombination immuno-oncology therapy with pembrolizumab, an anti-PD-1 monoclonal antibody targeting immune evasion, and standard chemotherapy for patients with the squamous and non-squamous subtypes of non-small cell lung cancer
P2860
Q55101776-16C20C9A-613D-4441-9756-893E367D6D82Q55378351-D5407785-042E-466C-B495-CA33A7C7E33DQ55518010-4A671730-9318-491B-9D79-94447DC85421Q57476222-99D66A5D-06AF-4B2D-A54E-E0DCE11FADFCQ57803800-83D90DB6-3342-41F5-9569-17EE5EFAD0AAQ58713932-93FE87D7-5FEB-486E-BE1C-1298F794E851Q58770914-BE8DCAD7-4CE0-454C-B7D8-E8B488B9425F
P2860
Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial.
description
2018 nî lūn-bûn
@nan
2018年の論文
@ja
2018年学术文章
@wuu
2018年学术文章
@zh
2018年学术文章
@zh-cn
2018年学术文章
@zh-hans
2018年学术文章
@zh-my
2018年学术文章
@zh-sg
2018年學術文章
@yue
2018年學術文章
@zh-hant
name
Axitinib in combination with p ...... dose-expansion phase 1b trial.
@en
Axitinib in combination with p ...... dose-expansion phase 1b trial.
@nl
type
label
Axitinib in combination with p ...... dose-expansion phase 1b trial.
@en
Axitinib in combination with p ...... dose-expansion phase 1b trial.
@nl
prefLabel
Axitinib in combination with p ...... dose-expansion phase 1b trial.
@en
Axitinib in combination with p ...... dose-expansion phase 1b trial.
@nl
P2093
P1433
P1476
Axitinib in combination with p ...... dose-expansion phase 1b trial
@en
P2093
Brad Rosbrook
Daniel C Cho
David F McDermott
Elizabeth R Plimack
Igor Puzanov
Jamal C Tarazi
Kathrine C Fernandez
Mariajose Lechuga
Mayer N Fishman
Michael B Atkins
P304
P356
10.1016/S1470-2045(18)30081-0
P577
2018-02-09T00:00:00Z